Wolfe Research Downgrades Moonlake Immunotherapeutics (MLTX) to Peerperform
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/2/2026
- US stocks set for higher open as AI trade steadies; midterms in focus
- Marvell agrees $115 billion all-stock deal to buy Lumentum
- Oil drops more than 4% on talks aimed at ending US-Iran war
- Why has the market become so unforgiving of AI earnings?
- EchoStar rises on report SpaceX in talks to buy Boost Mobile or tap its network
| (NASDAQ: MLTX) | Delayed: 11.78 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $11.78 | 52 Week High | $ | |||
| Open | $11.78 | 52 Week Low | $ | |||
| Day High | $11.78 | P/E | N/A | |||
| Day Low | $11.78 | EPS | $ | |||
| Volume | 57 | |||||
